In accordance with the ultimate steering for the second cycle of your Drug Price Negotiation Plan, drug corporations with a particular drug can have till February 28, 2025 to make a decision if they'll be involved in negotiations. In negotiating with taking part brands, CMS will consider the chosen drug’s scientific benefit, the extent to which i